A study of tryptophan metabolism via serotonin in ventricular cerebrospinal fluid in HIV-1 infection using a neuroendoscopic technique

Current HIV Research

Volumn 5, Issue 2, 2007, Pages 267-272

  Longatti, Pierluigi ^a   Perin, Alessandro ^a   Comai, Stefano ^a   Bertazzo, Antonella ^a   Rizzo, Vittoria ^b   Costa, Carlo Virgilio Luigi ^a   Allegri, Graziella ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Endoscopy; HIV 1; Hydrocephalus; Tryptophan; Ventricular CSF; Via serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; MELATONIN; SEROTONIN; TRYPTOPHAN;

ADULT; ANASTOMOSIS; BRAIN THIRD VENTRICLE; BRAIN VENTRICLE; CASE REPORT; CEREBROSPINAL FLUID; CHOROID PLEXUS; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYDROCEPHALUS; INCIDENTAL FINDING; MALE; NEUROENDOSCOPY; REVIEW; TRYPTOPHAN METABOLISM; AGED; ARTICLE; ENDOSCOPY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PATHOGENICITY; VIROLOGY;

5-HYDROXYTRYPTOPHAN; ADULT; AGED; CEREBRAL VENTRICLES; ENDOSCOPY; HIV INFECTIONS; HIV-1; HUMANS; HYDROCEPHALUS; HYDROXYINDOLEACETIC ACID; MALE; MELATONIN; SEROTONIN; TRYPTOPHAN; VENTRICULOSTOMY;

EID: 33947605761     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016207780077020     Document Type: Review

References (59)

1. Achim CL, Heyes MP, Wiley CA. (1993). Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brain. Journal of Clinical Investigation. 91: 2769-2775.
2. Ashcroft GW, Blackburn IM, Eccleston D, Glen AI, Hartley W, Kinloch NE, Lonergan M, Murray LG, Pullar IA. (1973). 5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration. Psychological Medicine. 3: 326-332.
3. Atkinson JH, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA. (1988). Prevalence of psychiatric disorders among men infected with human immunodeficiency virus; a controlled study. Archives of General Psychiatry. 45: 859-864.
4. Berger JR, Kumar M, Kumar A, Fernandez JB, Levin B. (1994). Cerebrospinal fluid dopamine in HIV-1 infection. AIDS. 8: 67-71.
5. Britton CB, Cote L, Altstiel L. (1989). Cerebrospinal fluid biogenic amine metabolites in patients with AIDS. Neurology. 39: 380.
6. Brown GL, Ebert MH, Goyer PF, Jimerson DC, Klein WJ, Bunney WE, Goodwin FK. (1982). Aggression, suicide, and serotonin: relationships to CSF amine metabolites. The American Journal of Psychiatry. 139: 741-746.
7. Catalan J, Klimes I, Day A, Garrod A, Bond A, Gallwey J. (1992). The psychosocial impact of HIV infection in gay men. A controlled investigation and factors associated with psychiatric morbidity. The British Journal of Psychiatry. 161: 774-778.
8. Comai S, Longatti P, Perin A, Bertazzo A, Ragazzi E, Costa CVL, Allegri G. (2006). Study of tryptophan metabolism via serotonin in cerebrospinal fluid of patients with noncommunicating hydrocephalus using a new endoscopic technique. Journal of Neuroscience Research. 84: 683-691.
9. Costa C, Bettero A, Allegri G. (1987). Rapid measurements of tryptophan, 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in human CSF by selective fluorescence and HPLC. Giornale Italiano di Chimica Clinica. 12: 307-312.
10. Dursun SM, Handley SL. (1992). Serotonin, eating disorders, and HIV infection. The British Journal of Psychiatry. 160: 866-867.
11. Dursun SM, Reveley MA. (1993). Low serum cholesterol and serotonin receptor subtypes. The British Journal of Psychiatry. 163: 417-418.
12. Dursun SM, Reveley MA. (1995). Serotonin hypothesis of psychiatric disorders during HIV infection. Medical Hypotheses. 44: 263-267.
13. Ebert MH, Perlow MJ. (1977). Utility of cerebrospinal fluid measurements in studies of brain monoamines. In: Usdin E, Weiner N, Youdim MBH Eds, Structure and Function of Monoamine Enzymes. New York, Marcel Dekker. pp. 963-984.
14. Eccleston D, Ashcroft GW, Crawford TB. (1970). Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. Journal of Neurolology, Neurosurgery, and Psychiatry. 33: 269-272.
15. Elliot AJ, Roy-Byrne PP. (1998). Major depressive disorders and HIV-1 infection: A review of treatment trials. Seminars in Clinical Neuropsychiatry. 3: 137-150.
16. Eriksson T, Lidberg L. (1996). Decreased plasma ratio of tryptophan to competing large neutral amino acids in human immunodeficiency virus type 1 infected subjects: possible implications for development of neuro-psychiatric disorders. Journal of Neural Transmission. 103: 157-164.
17. Fernstrom JD, Wurtman RJ. (1971). Brain serotonin content: physiologic dependence on plasma tryptophan levels. Science. 173: 149-152.
18. Fuchs D, Forsman A, Hagberg L, Larsson M, Norkrans G, Reibnegger G, Werner ER, Wachter H. (1990). Immune activation and decreased tryptophan in patients with HIV-1 infection. Journal of Interferon Research. 10: 599-603.
19. Fuchs D, Moller AA, Reibnegger G, Stockle E, Werner ER, Wachter H. (1990). Decreased serum trytophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/ psychiatric symptoms. Journal of Acquired Immune Deficiency Syndromes. 3: 873-876.
20. Garelis E, Young SN, Lal S, Sourkes TL. (1974). Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. Brain Research. 79: 1-8.
21. Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP. (1992). Interrelationship between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1 infected patients. Journal of Neuroimmunology. 40: 71-80.
22. Heyes MP, Saito K, Lackner A, Wiley CA, Achim CL, Markey SP. (1998). Sources of the neurotoxin quinolinic acid in the barin of HIV-1-infected patients and retrovirus-infected macaques. FASEB Journal. 12: 881-896.
23. Heyes MP, Saito K, Markey SP. (1992). Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Journal of Biochemistry. 83: 633-635.
24. Hortin GL, Landt M, Powderly WG. (1994). Changes in plasma amino acid concentrations in response to HIV-1 infection. Clinical Chemistry. 40: 785-789.
25. Huengsberg M, Winer JB, Gompels M, Round R, Ross J, Shahmanesh M. (1998). Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV infected patients. Clinical Chemistry. 44: 858-862.
26. Jones RFC, Kwok BC, Stening WA, Vonau M. (1994). Neuroendoscopic third ventriculostomy. A practical alternative to extracranial slump in non-communicating hydrocephalus. Acta Neurochirurgica. Supplement. 61: 79-83.
27. Jones RFC, Kwok BC, Stening WA, Vonau M. (1994). The current status of endoscopic third ventriculostomy in the management of non-communicating hydrocephalus. Minimally Invasive Neurosurgery. 37: 28-36.
28. Kumar AM, Berger JR, Eisdorfer C, Fernandez JB, Goodkin K, Kumar M. (2001). Cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in HIV-1 infection. Neuropsychology. 44: 13-18.
29. Larsson M, Hagberg L, Forsman A, Norkraus G. (1991). Monoaminergic transmitter systems during HIV infection. VII Int. Conf. On AIDS, Florence-Italy, abstract MB2018.
30. Larsson M, Hagberg L, Norkrans G, Forsman A. (1989). Indole amine deficiency in blood and cerebrospinal fluid from patient with human immunodeficiency virus infection. Journal of Neuroscience Research. 23: 441-446.
31. Launay JM, Copel L, Callebert J, Corvaia N, Bricaire F, Laplanche JL, Saal F, Peries J. (1989). Serotonin and human immunodeficiency viruses. Nouvelle Revue Francaise d'Hematologie. 31: 159-161.
32. Law WA, Martin A, Salazar AM, Mapou RL. (1993). Symptoms of depression in HIV-infected individuals. Etiological considerations. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 6: 181-186.
33. Lipton SA. (1992). Models of neuronal injury in AIDS: another role for the NMDA receptor?. Trends in Neurosciences. 15: 75-79.
34. Longatti P, Perin A, Rizzo V, Comai S, Bertazzo A, Allegri G. (2004). Endoscopic selective samplimg of human ventricular CSF: A new perspective. Minimally Invasive Neurosurgery. 47: 350-354.
35. Lopez-Ibor JJ Jr (1989). The involvement of serotonin in psychiatric disorders and behaviour. The British Journal of Psychiatry. Supplement. 153(3): 26-39.
36. Martin A, Heyes MP, Salazar AM, Kampen DL, Williams J, Law WA, Coats ME, Markey SP. (1992). Progressive slowing of reaction time and increasing cerebrospinal fluid concentration of quinolinic acid in HIV-1 infected individuals. The Journal of Neuropsychiatry and Clinical Neurosciences. 4: 270-279.
37. McKegney FP, O'Dowd MA. (1992). Suicidality and HIV status. The American Journal of Psychiatry. 149: 396-398.
38. Meltzer HY. (1991). The significance of serotonin for neuropsychiatric disorders. The Journal of Clinical Psychiatry. 52: 70-72.
39. Moir ATB, Ashcroft GW, Crawford TB, Eccleston D, Guldberg HC. (1970). Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain. 93: 357-368.
40. Murray MF, Langan M, MacGregor RR. (2001). Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide. Nutrition. 17: 654-656.
41. Murray MF, Srinivasan A. (1995). Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection. Biochemical and Biophysical Research Communications. 210: 954-959.
42. Murray MF. (2003). Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. The Lancet Infectious Diseases. 3: 644-652.
43. Natlan CF, Murray HW, Wiebe ME, Rubin BY. (1983). Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. Journal of Experimental Medicine. 58:670-689.
44. Ramsay N, Catalan J, Gazzard B. (1992). Eating disorders in men with HIV infection. The British Journal of Psychiatry. 160: 404-407.
45. Rizzo V, Porta C, Moroni M, Scoglio E, Moratti R. (2002). Determination of free and total (free plus protein-bound) melatonin in plasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B. 774: 17-24.
46. Sardar AM, Reynolds GP. (1995). Frontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia. Neuroscience Letters. 187: 9-12.
47. Schaefer FW, Miller RR, Lipsey JR, McPherson RW. (1989). ECT for major depression in four patients infected with human immunodeficiency virus. The American Journal of Psychiatry. 146: 782-784.
48. Smith DG, Guillemin GJ, Pemberton L, Kerr S, Nath A, Smythe GA, Brew BJ. (2001). Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. Journal of Neurovirology. 7: 56-60.
49. Tagliamonte A, Tagliamonte P, Perez-Cruet J, Gessa GL. (1971). Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis. Nature: New biology. 27: 125-126.
50. Teo C. (1998). Third ventriculostomy in the treatment of hydrocephalus: experience with more than 120 cases. In: Hellvig D, Bauer BL Eds, Minimally invasive techniques for neurosurgery. Berlin, Springer-Verlag. pp. 73-76.
51. Tricoire H, Locatelli A, Chemineau P, Malpaux B. (2002). Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology. 143: 84-90.
52. Tricoire H, Malpaux B, Moller M. (2003). Cellular lining of the sheep pineal recess studied by light-, transmission-, and scanning electron microscopy: morphologic indications for a direct secretion of melatonin from the pineal gland to the cerebrospinal fluid. The Journal of Comparative Neurology. 456: 39-47.
53. Tricoire H, Moller M, Chemineau P, Malpaux B. (2003). Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod. Reproduction Supplement. 61: 311-321.
54. Werner ER, Fuchs D, Hausen A, Jaeger H, Reibnegger G, Werner-Felmayer G, Dierich MP, Wachter H. (1988). Tryptophan degradation in patients infected by human immunodeficiency virus. Biological Chemistry Hoppe-Seyler. 369: 337-340.
55. Wiegand M, Moller AA, Schreiber W, Krieg JC, Fuchs D, Wachter H, Holsboer F. (1991). Nocturnal sleep EEG in patients with HIV-infection. European Archives of Psychiatry and Clinical Neuroscience. 240: 153-158.
56. Yoshida R, Imanishi J, Oku T, Kishida T, Hayaishi O. (1981). Induction of pulmonary indoleamine 2,3-dioxygenase by interferon. Proceedings of the National Academy of Sciences of the United States of America. 78: 129-132.
57. Young SN, Anderson GM, Gauthier S, Purdy WC. (1980). The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid. Journal of Neurochemistry. 34: 1087-1092.
58. Young SN, Etienne P, Sourkes TL. (1976). Relationship between rat brain and cisternal CSF tryptophan concentrations. Journal of Neurolology, Neurosurgery, and Psychiatry. 39: 239-243.
59. Zangerle R, Widner B, Quirchmair G, Neurauter G, Sarcletti M, Fuchs D. (2002). Effective antiretroviral theraphy reduces degradation of tryptophan in patients with HIV-1 infection. Clinical Immunology. 104: 242-247.